semaglutide before colonoscopy 2-Day MiraLAX® semaglutide and colonoscopy Ulcerative Colitis:

Common side effects shared by both medications: Nausea (most common, usually transient peaks during dose escalation) Vomiting Diarrhea or constipation Decreased appetite and early satiety Bloating or stomach discomfort Injection site reactions Key safety warnings that apply to both drugs: FDA Boxed Warning (both): Possible risk of thyroid C-cell tumors, based on animal studies

Ideal candidates for semaglutide weight loss programs typically have a body mass index over 30, or a BMI of 27 with associated medical conditions like hypertension, type 2 diabetes, or elevated cholesterol

These effects happen regardless of the indication the medication is prescribed for, which is why the weight loss properties of Ozempic became so widely discussed even though weight management was never its licensed purpose in the UK

Realistic expectation levels and understanding of treatment limitations contribute to higher satisfaction rates